K2 BioLabsPonce TherapeuticsPortfolioRapha Capital Management New Biotechnology Research Accelerator Launches in Houston
PortfolioRapha Capital Management Rapha Capital Management Announces First Managed Venture Fund Focused on Investment in Early-Stage Biotech Startups
PortfolioRapha Capital Management Rapha Capital Management Announces Successful Initial Public Offering of Portfolio Company NexImmune Inc.
Ponce TherapeuticsPortfolioRapha Capital Management Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin
PortfolioRapha Capital Management AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
PortfolioRapha Capital Management NexImmune Strengthens Scientific Leadership by Appointing Jerome Zeldis as EVP R&D and Jeffrey Weber as Chief Scientific Advisor
PortfolioRapha Capital Management Preliminary Results from NexImmune’s Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition
PortfolioRapha Capital Management Rapha Capital Management Participates in Series D Financing for Poseida Therapeutics
